Press
 

Company press release

 

Proteo, Inc. listed and quoted in the over the counter segment of the Frankfurt Stock Exchange

Kiel, August 16, 2004: Proteo, Inc. [NASDAQ-OTCBB: PTEO] announced that its shares are now additionally listed and quoted in the over the counter segment of the Frankfurt Stock Exchange (FSE) under the trading symbol (WKN) 925981. So far Proteos stocks (ticker symbol PTEO) were solely listed at the OTCBB market of the NASDAQ.

“The additional listing at the over the counter segment of the Frankfurt Stock Exchange (FSE) represents the progress and advancement our company is going through. We have just completed successfully the preclinical trials of our flagship product ELAFIN and are now focussed on phase I of its clinical evaluation” said Walter J. Thomsen, CEO of Proteo, Inc.

Contact

Barbara Kahlke, Ph.D.
Proteo Biotech AG
Am Kiel-Kanal 44
D-24106 Kiel

Email: info@proteo.de
Telephone: +49 431 8888-462
Fax: +49 431 8888-463

https://proteo.de/pages/press/press-releases/2004/08/16/proteo,-inc.-listed-and-quoted-in-the-over-the-counter-segment-of-the-frankfurt-stock-exchange/ – printed on 2020-09-23 21:03:39